Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well he was accused of hiding the P data, not wanting to disclose. So I took this statement as nipping that view in the bud.
You want to slap the shorts upside the head…lol! Well we know it won’t be too long anyway.
Leo said a week after data lock in the PR.
Having a PR for data lock gives everyone knowledge that a week is left for top line results.
That’s what I learned from the PR, all is executing on schedule.
RIP that is sad. Hopefully her family will benefit from her IPIX patience, believing and tenacity. It wasn’t easy being a long for so many years.
Excellent point. I’m sure part of the reason for a 60 day follow up was to see if there alive or back in the hospital.
Oh and .26, missed one lol!
How do you sell at .15. .20 .28 .30 ? Hmmm?
So that is certainly plausible. BP buyout, partnership, grants also can change the outlook greatly!
The next step in the Short Biotech hedge fund playbook is to smear the results, even if they are good. This could only impact the share price briefly depending on how good they are. Now if it’s cure level this will explode regardless. The patients are almost post viral load help so it’s a tough group for clear efficacy IMO. What we have going for us is Rem is worthless.
Need to wait for most of that post for results. Why would Leo request anything prior to results? As for AS who knows.
Like I said no one knows Squat so stop the baby tears. DB lock is on the clock, one week post lock results.
I sure hope so. I’d 2X my position.
A lot of dark pool action. Need the SEC to approve the full disclosure rule.
Adding today on the scare tactic drop. No one knows squat, no PR.
Typical playbook stuff with a biotech ready to report on a large catalyst! Scare the heck out of people as if the news is already known and it must be bad. Truth, no one knows squat!
Never put stops on a stock like IPIX. MM’s work the sells tell they trigger them.
No longs are leaving or putting a negative spin on trial, Leo , B. We’re use to the swings by MM’s. Can hardly wait for results!!!
Why you should add, take advantage.
Does anyone believe a trading range of .30001 to .30038 is legitimate? What a crock. SEC is another worthless governor entity. Probably looking at more porn on the internet.
So the CRO is the one that discloses the results to Leo. Material information must be reported in one business day of disclosure. So no one is hiding anything DuD.
Good thing the trial results are soon. And most of it conducted in Russia. I think the length of the pandemic and variants is now causing enough concern to give B a chance. Too bad it could have been done last year.
Excellent points Pete, which points out there is no entity more corrupt and incompetent as government entities. And some want socialism, even though it destroys everyone’s standard of living. The FDA had to give BP pay to play participants the first go at it. Even though Rem really didn’t prove itself at all and failed all prior trials to Covid. Now they found ways to drag out B’s trial to give Merck’s and PFE’s treatments coming soon on PHIII results first dibs. How does the top identified treatment from the RBL’s not get funding or priority? What is the purpose of the RBL’s. My opinion is the RBLs we’re used to put on a front to show people look at all we’re doing to find a treatment. And also test new and old treatments from BP. When B did so well they probably went oh sh$t this wasn’t suppose to happen now we have to find ways to keep this on the back burner after BP gets multiple shots on goal. And if BP fails well we have a backup plan. All hoping for a board or executive position at a BP down the road.
Also what’s being measured is broken up into many parts one of which is top-line on primary efficacy endpoints, which is the shortest in terms of reporting.
After each patient completed their time data is collected, then called post 60 days. So their shouldn’t be any left at this point, per my understanding.
As soon as they have data lock, which IMO is any time now, the can run the top line with a click of a button. Then they will know group A results is = to XXX and group B is YYY. Next they unblind you see what treatment is with group A and same with group B. Can they report on this No. They will go through more validation steps. How long that takes shouldn’t be more than a week to a few days…all IMO.
Ok , I actually can run with that, a buyout for the right price is always welcomed. I’d prefer an all stock transaction so I can manage the tax implications, and still participate in B’s evolution and the acquiring company’s future.
Should see a data lock soon. Unless they can’t get the Ivan to answer the phone or maybe he’s holding out for a ransom payment before he answers a call from Innovation P? What a goofy requirement, a 60 day follow-up call.
I would say that near zero success is priced in the stock on the results. News on trial progress is always good. AS news and $$$ would be great. OTC stocks $$$ matter!
B actually should now be the RBL’s top candidate after the conference and comparing to other treatments they are looking at. The only reason it’s waiting in line for Delta variant testing is the pay-to-play BP’s get to try their already failed drugs first or quickly made up drug to pounce on the treatment opportunity.
That a big assumption to say 100% will die of the 1/300th. Need to take the 1/300th now and multiply by the CV death rate.
Why does anything have to make sense anymore; especially in a world ruled by Apes. Look at Robinhood now at $58 billion in two days of trading . We need the Apes to come on board with good data and make “The Man” pay!
It’s the OTC , trading means zero until data and or $$$.
Like yesterday, I’ll be adding.
The variants and vaccines declines in effectiveness so fast is a surprise to all. So much so that B , although moving like a tortoise may end up winning the race. Results on deck.
Data hasn’t been locked. Until then the process of unblinding cannot start. Like I said the CRO is following the trial protocol, which is their job. Leo is waiting like all of us.
Leo is not At fault for the trial length blame that on the pay to play setup where $$$ not lives matter to those in power. Leo has to play the book given to him or not get a shot at all. The trial will complete per the protocol, if not the results will be negated. I think we’re all better off finishing the trial by not committing any penalties and reason to invalidate the trial.
I’m upset with how long Fast Track (laughable) has taken. I believe it has to do with MRK & PFE having PHIII antivirals results coming and they wanted to be sure they get first dibs. So the B trial requirements were designed to drag out as long as possible. Yes, Pay to play!
Added at close. Countdown has started. There is little time left!